Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Stefan Schwartz"'
Autor:
Pilar Martínez Sánchez, Gerhard Zugmaier, Paul Gordon, Elias Jabbour, José J. Rifón Roca, Stefan Schwartz, Erika Borlenghi, Francoise Huguet, Jesús María Hernández-Rivas, Federico Lussana, Céline Berthon, Priti Kadu, Hansen Wong, Ana Markovic, Yuliya Katlinskaya, Alessandro Rambaldi
Publikováno v:
Blood. 140:6122-6124
Autor:
Nicola Goekbuget, Andreas Viardot, Björn Steffen, Joachim Hahn, Bernd Spriewald, Sonja Martin, Simon Raffel, Lino L. Teichmann, Arne Trummer, Winfried Alsdorf, Anke Morgner, Stefan Schwartz, Matthias Stelljes, Vladan Vucinic, Nael Alakel, Andrea Stoltefuß, Claudia D. Baldus, Monika Brüggemann, Hubert Serve, Dieter Hoelzer
Publikováno v:
Blood. 140:121-123
Autor:
Nicola Goekbuget, Walter Fiedler, Nael Alakel, Max S. Topp, Maher Hanoun, Björn Steffen, Ralph Wäsch, Andreas Viardot, Kathrin Nachtkamp, Matthias Stelljes, Hendrik Poeck, Vladan Vucinic, Boris Böll, Joachim Beck, Lars Fransecky, Knut Wendelin, Folker Schneller, Christoph Faul, Veit L Buecklein, Lena Reiser, Monika Brüggemann, Hubert Serve, Stefan Schwartz
Publikováno v:
Blood. 140:115-117
Autor:
Sunita Choudhary, Jan Masner, Stefan Schwartz, Serkan Kartal, Jana Kholova, Priyanka Gattu, Michal Stočes, Ewaut Kissel
Publikováno v:
Sensors; Volume 21; Issue 23; Pages: 8022
Sensors (Basel, Switzerland)
Sensors, Vol 21, Iss 8022, p 8022 (2021)
Sensors (Basel, Switzerland)
Sensors, Vol 21, Iss 8022, p 8022 (2021)
This study tested whether machine learning (ML) methods can effectively separate individual plants from complex 3D canopy laser scans as a prerequisite to analyzing particular plant features. For this, we scanned mung bean and chickpea crops with Pla
Autor:
Pilar Martínez Sánchez, Paul Gordon, Stefan Schwartz, Giuseppe Rossi, Francoise Huguet, Jesus Maria Hernández-Rivas, Priti Kadu, Hansen L. Wong, Ana Markovic, Yuliya Katlinskaya, Bharat Panwar, Gerhard Zugmaier
Publikováno v:
Blood. 138:2303-2303
Background Blinatumomab is a BiTE ® (bispecific T cell engager) molecule that engages patients' T cells to the CD19 antigen on lymphoid tumor cells. Blinatumomab administered as a 28-day continuous intravenous infusion (cIV) is approved in multiple
Autor:
Vladan Vucinic, Andrea Renzelmann, Monika Brüggemann, Stefan Schwartz, Nicola Goekbuget, Bernd Hertenstein, Andreas Viardot, Maria Wachsmuth, Andrea Stoltefuß, Max S. Topp, Christoph Faul, Lena Baumann, Diana Tichy, Anne C. Wilke
Publikováno v:
Blood. 138:3399-3399
Older patients (pts) with newly diagnosed ALL are ineligible for unmodified pediatric-based therapies. Even with age-adapted, dose-reduced regimens early death rates (ED) are considerable and overall survival (OS) poor. Thus, 412 pts treated accordin
Autor:
Claudia D. Baldus, Johannes Duell, Christoph Faul, Miriam Kelm, Johanna Richter, Johannes Gärtner, Britta Kehden, Andreas Viardot, Stefan Schwartz, Matthias Ritgen, Kathrin Nachtkamp, Nicola Goekbuget, Björn Steffen, Monika Szczepanowski, Heiko Trautmann, Monika Brüggemann
Publikováno v:
Blood. 138:2301-2301
Introduction Rituximab (R) administration results in significant outcome improvement in B cell precursor acute lymphoblastic leukemia (B-ALL) patients (pts), but is usually restricted to pts with ≥20% CD20+ leukemic blasts. Yet, this arbitrary cut-
Autor:
Matthias Stelljes, Heike Pfeifer, Folker Schneller, Joachim Beck, Boris Böll, Maher Hanoun, Monika Brüggemann, Christoph Faul, Nicola Goekbuget, Sonja Martin, Ralph Wäsch, Stefan Schwartz, Thomas Burmeister, Walter Fiedler, Andreas Viardot, Max S. Topp, Knut Wendelin, Björn Steffen, Vladan Vucinic, Nael Alakel, Diana Tichy, Lena Baumann, Hubert Serve, Kathrin Nachtkamp, Claudia D. Baldus, Karsten Spiekermann
Publikováno v:
Blood. 138:362-362
In the past decade outcome of adult ALL was improved significantly using pediatric-based chemotherapy in combination with risk-adapted stem cell transplantation (SCT) and targeted therapies. The GMALL Trial 08/2013 (NCT02881086) for patients (pts) ag
Autor:
Andreas Viardot, Monika Brüggemann, Nicola Goekbuget, Thomas Burmeister, Mustafa Kondakci, Sören Franzenburg, Max S. Topp, Christoph Faul, Andre Franke, Stefan Schwartz, Folker Schneller, Claudia D. Baldus, Sonja Hänzelmann, Heiko Trautmann, Walter Fiedler, Martin Neumann, Alina Hartmann, Lorenz Bastian
Publikováno v:
Blood. 136:11-12
Targeted interventions and new risk stratification approaches for the improvement of outcomes in B cell precursor acute lymphoblastic leukemia (BCP-ALL) require an understanding of high-risk driver subtypes, their clinical phenotypes and actionable t
Autor:
Nael Alakel, Folker Schneller, Jutta Ortiz Tanchez, Heiko Trautmann, Carsten Müller-Tidow, Martin Neumann, Cornelia Schlee, Lorenz Bastian, Mustafa Kondakci, Michael P Schroeder, Walter Fiedler, Nicola Goekbuget, Stefan Schwartz, A. Reichle, Philipp A. Greif, Sonja Hänzelmann, Monika Brüggemann, Lars Fransecky, Thomas Burmeister, Michael Starck, Alina Hartmann, Sebastian Vosberg, Claudia D. Baldus
Publikováno v:
Blood. 136:37-38
Introduction: In T-ALL, in contrast to BCP-ALL, molecular subgroups are less well defined. Molecular subgroups are based on aberrant expression of oncogenes often resting upon structural aberrations (chromosomal translocation, copy number variations,